The objective is to evaluate therapeutic efficacy of 2 grams nano-phytosterols daily supplemention on diagnosis criteria of metabolic syndrome.

Inclusion Criteria:

• Informed consent written
• Available subjects to follow-up visits
• Subjects with diagnoses of metabolic syndrome 5 years ago or with current diagnoses criteria
• Subjects with health visits ongoing
• Subjects with arterial hypertension under control.
• Subjects with mellitus diabetes under control.

Exclusion Criteria:

• Subjects with alcoholism history.
• Subjects with history of sitosterolemia.
• Subjects with familiar hypercholesterolemia
• Subjects who are consuming phytosterols
• Pregnancy women
• Breastfeeding period women
• Subjects with personal history of: acute miocardical infarction, stroke, hypertensive emergency, acute or chronic diabetes descompensation

PI will share IPD after doing all possible publications.